Carly Grant is a Senior Genetic Counselor at the Massachusetts General Hospital (MGH) Center for Cancer Risk Assessment (CCRA), which she joined in 2015. She received her Master’s degree in Genetic Counseling from Brandeis University in 2005 and her Bachelor’s degree in Molecular Biology from Haverford College in 1997. Before joining MGH, Ms. Grant provided cancer genetic counseling for adults and children at the Dana-Farber Cancer Institute and the Jimmy Fund. At the MGH CCRA, she offers personalized risk assessment and genetic counseling services in breast, ovarian, and gastrointestinal cancer genetics. Ms. Grant specializes in pediatric cancer genetic counseling and co-founded the Pediatric Oncology Genetics clinic at MGH. Ms. Grant is passionate about supporting patients as they navigate the emotional and psychological challenges of hereditary cancer syndromes. She enjoys teaching genetics to patients, families, students, and healthcare professionals. Ms. Grant has a special interest in Li-Fraumeni syndrome and currently serves as the Medical Advisory Chair for the patient advocacy organization Living LFS.
Testing for the classic hereditary breast cancer genes, BRCA1 and BRCA2, has been available and widely offered since their discovery in the 1990s. However, new technologies in genetic testing have recently uncovered information about other genes linked to hereditary breast cancer.
